Moreover, the IRS of BRCC3 in grade IV GBM tissues was higher than normal cortical tissues (Fig. 1F), indicating that the high level of BRCC3 expression is associated with tumor cell growth during glioma progression. The gene discussed is BRCC3; the disease is central nervous system cancer.